JILL MCCARTNEY: Open Payments
NPI 1598364028 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,105 in 55 payments from 10 companies in 2025. Trend: 2023 $709 · 2024 $1,227 · 2025 $1,105
Food & beverage: $1,105
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 13 | $307 |
| Neurocrine BioSciences, Inc. | 12 | $185 |
| Alkermes, Inc. | 8 | $171 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $159 |
| Teva Pharmaceuticals USA, Inc. | 5 | $99 |
| Janssen Pharmaceuticals, Inc | 4 | $85 |
| Supernus Pharmaceuticals, Inc. | 3 | $48 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| Almatica Pharma LLC | 1 | $14 |
Products named: Auvelity, INGREZZA, ARISTADA, CAPLYTA, SPRAVATO, AUSTEDO XR, Qelbree, UZEDY.
Industry payments across PA — which companies pay providers there.
